This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Natelson, B. H.
Right arrow Articles by Ottenweller, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Natelson, B. H.
Right arrow Articles by Ottenweller, J. E.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, January 2005, p. 52-55, Vol. 12, No. 1
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.1.52-55.2005

Spinal Fluid Abnormalities in Patients with Chronic Fatigue Syndrome

Benjamin H. Natelson,1* Shelley A. Weaver,1 Chin-Lin Tseng,2 and John E. Ottenweller1

CFS Cooperative Research Center,1 Department of Neurosciences and Department of Preventive Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, New Jersey2

Received 2 May 2004/ Returned for modification 3 September 2004/ Accepted 6 October 2004

Arguments exist as to the cause of chronic fatigue syndrome (CFS). Some think that it is an example of symptom amplification indicative of functional or psychogenic illness, while our group thinks that some CFS patients may have brain dysfunction. To further pursue our encephalopathy hypothesis, we did spinal taps on 31 women and 13 men fulfilling the 1994 case definition for CFS and on 8 women and 5 men serving as healthy controls. Our outcome measures were white blood cell count, protein concentration in spinal fluid, and cytokines detectable in spinal fluid. We found that significantly more CFS patients had elevations in either protein levels or number of cells than healthy controls (30 versus 0%), and 13 CFS patients had protein levels and cell numbers that were higher than laboratory norms; patients with abnormal fluid had a lower rate of having comorbid depression than those with normal fluid. In addition, of the 11 cytokines detectable in spinal fluid, (i) levels of granulocyte-macrophage colony-stimulating factor were lower in patients than controls, (ii) levels of interleukin-8 (IL-8) were higher in patients with sudden, influenza-like onset than in patients with gradual onset or in controls, and (iii) IL-10 levels were higher in the patients with abnormal spinal fluids than in those with normal fluid or controls. The results support two hypotheses: that some CFS patients have a neurological abnormality that may contribute to the clinical picture of the illness and that immune dysregulation within the central nervous system may be involved in this process.

* Corresponding author. Mailing address: Fatigue Research Center (129), VA Medical Center, 385 Tremont Ave., East Orange, NJ 07018. Phone: (973) 395-7737. Fax: (973) 395-7114. E-mail: bhn{at}njneuromed.org.

Clinical and Diagnostic Laboratory Immunology, January 2005, p. 52-55, Vol. 12, No. 1
1071-412X/05/$08.00+0     doi:10.1128/CDLI.12.1.52-55.2005






Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»